Einstellung des Insulin-Kohlenhydrat-Verhältnisses, des Korrekturfaktors, der Insulindosierung und des Zeitpunkts der Insulinabgabe durch eine Medikamentenabgabevorrichtung

Details

Veröffentlichungs-Nr.

EP4141879

Aktenzeichen

EP22191622

Anmeldetag

23. August 2022

Veröffentlichung

24. Mai 2023

Rechtsraum

EP

IPC

G16H20/17G16H40/63G16H50/20G16H50/30

Abstract

The insulin to carbohydrate ratio (ICR) and the correction factor for a user of a medicament delivery device may be automatically adjusted. The automatic adjustments may tailor the values to the user's actual insulin needs. Various factors may be examined to determine how to adjust the ICR and the correction factor. The identified factors are weighed with the processor to decide whether to increase or decrease the insulin to carbohydrate ratio or the correction factor. The insulin to carbohydrate ratio or the correction factor for the user are adjusted based on the weights of the identified factors. In addition or in the alternative, automatic adjustments of user-requested insulin boluses may be made to requested dosages and timing of deliveries of the insulin boluses. In some instances, the exemplary embodiments may deliver a percentage of the insulin bolus dosage initially and deliver the remaining percentage after a delay to reduce the risk of hypoglycemia for the user.

Anmelder

Firma

Insulet Corporation

Land

🇺🇸 USA

Fachgebiete